Temporal Changes in the Treatment Paradigm and Long-term Prognosis of Patients With Crohn's Disease: A Hospital-Based Cohort Study in China.
Lingya YaoHaotian ChenBule ShaoJing LiuChaohui WangZhou ZhangQian CaoPublished in: Inflammatory bowel diseases (2022)
Infliximab use was observed to increase as 5-ASA and corticosteroid use decreased. Additionally, hospitalization rates decreased following temporal changes in IFX management, yet the surgery and phenotype progression rates remained the same.